1. Home
  2. KRYS vs DRVN Comparison

KRYS vs DRVN Comparison

Compare KRYS & DRVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KRYS
  • DRVN
  • Stock Information
  • Founded
  • KRYS 2015
  • DRVN 1972
  • Country
  • KRYS United States
  • DRVN United States
  • Employees
  • KRYS N/A
  • DRVN N/A
  • Industry
  • KRYS Biotechnology: Biological Products (No Diagnostic Substances)
  • DRVN Automotive Aftermarket
  • Sector
  • KRYS Health Care
  • DRVN Consumer Discretionary
  • Exchange
  • KRYS Nasdaq
  • DRVN Nasdaq
  • Market Cap
  • KRYS 3.6B
  • DRVN 3.0B
  • IPO Year
  • KRYS 2017
  • DRVN 2021
  • Fundamental
  • Price
  • KRYS $133.05
  • DRVN $17.01
  • Analyst Decision
  • KRYS Strong Buy
  • DRVN Buy
  • Analyst Count
  • KRYS 8
  • DRVN 10
  • Target Price
  • KRYS $211.13
  • DRVN $20.00
  • AVG Volume (30 Days)
  • KRYS 320.8K
  • DRVN 709.2K
  • Earning Date
  • KRYS 08-04-2025
  • DRVN 07-31-2025
  • Dividend Yield
  • KRYS N/A
  • DRVN N/A
  • EPS Growth
  • KRYS 109.01
  • DRVN N/A
  • EPS
  • KRYS 4.16
  • DRVN N/A
  • Revenue
  • KRYS $333,448,000.00
  • DRVN $2,373,759,000.00
  • Revenue This Year
  • KRYS $44.05
  • DRVN N/A
  • Revenue Next Year
  • KRYS $46.15
  • DRVN $8.01
  • P/E Ratio
  • KRYS $31.77
  • DRVN N/A
  • Revenue Growth
  • KRYS 247.53
  • DRVN 6.75
  • 52 Week Low
  • KRYS $122.80
  • DRVN $11.45
  • 52 Week High
  • KRYS $219.34
  • DRVN $18.72
  • Technical
  • Relative Strength Index (RSI)
  • KRYS 44.16
  • DRVN 43.32
  • Support Level
  • KRYS $127.99
  • DRVN $16.82
  • Resistance Level
  • KRYS $143.20
  • DRVN $17.30
  • Average True Range (ATR)
  • KRYS 4.23
  • DRVN 0.52
  • MACD
  • KRYS 1.01
  • DRVN -0.12
  • Stochastic Oscillator
  • KRYS 44.48
  • DRVN 11.84

About KRYS Krystal Biotech Inc.

Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is focused on the development of easy-to-use, redosable gene therapies to improve the lives of patients living with debilitating diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments for rare or orphan dermatological indications caused by the absence of or a mutation in a single gene. It plans to leverage its platform to expand its pipeline to include other dermatological indications in the future. The company has one operating segment, which is the business of developing and commercializing pharmaceutical products.

About DRVN Driven Brands Holdings Inc.

Driven Brands Holdings Inc is an automotive services company in North America. Its platform provides high-quality services to an extensive range of retail and commercial customers. The company provides an extensive range of core consumer and commercial automotive needs, including paint, collision, glass, and repair services, as well as a variety of high-frequency services, such as oil changes and car washes. The company segments include: Maintenance, Car Wash, Paint, Collision & Glass, and Platform Services. It derives maximum revenue from Maintenance Segment. Geographically, the company operates into United States, Canada and Rest of the World.

Share on Social Networks: